Filing Details
- Accession Number:
- 0001179110-13-005151
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2013-03-14 17:22:19
- Reporting Period:
- 2013-03-14
- Filing Date:
- 2013-03-14
- Accepted Time:
- 2013-03-14 17:22:19
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 884629 | Actavis Inc. | ACT | Pharmaceutical Preparations (2834) | 953872914 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1471459 | M Charles Mayr | Morris Corporate Center Iii 400 Interpace Parkway Parsippany NJ 07054 | Chief Communic Off-Global | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock, Par Value $0.0033 | Disposition | 2013-03-14 | 1,000 | $91.77 | 28,310 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $91.77 to $91.78, inclusive. The reporting person undertakes to provide to Actavis, Inc., any security holder of Actavis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (1) to this Form 4.
- Includes shares of restricted stock issued pursuant to the Fourth Amendment and Restatement of the 2001 Incentive Award Plan of Actavis, Inc., as amended.
Billionaire Hedge Funds
